Formatech has introduced a “Fillanthropy” Program, under which the company will donate an aseptic fill and finish manufacturing service each month for selected therapeutic candidates entering human trials. “At Formatech, we envision a world where all companies with promising new drug therapies have the opportunity to conduct a full clinical development program,” said Jeffrey Bernard, director of business development. “We have observed that the current economic climate has hindered the progres...